Clinical burden and work productivity impairment in moderate-to-severe atopic dermatitis patients in the United States

被引：0
|
作者：
Feldman, Steven R. [1 ]
Guerin, Annie [2 ]
Gauthier-Loiselle, Marjolaine [2 ]
Claxton, Ami J. [3 ]
Hazra, Nisha C. [4 ]
Meng, Yan [4 ]
Gallant, Kirsten [4 ]
Balu, Sanjeev [3 ]
机构：
[1] Wake Forest Univ, Sch Med, Winston Salem, NC USA
[2] Anal Grp Inc, Montreal, PQ, Canada
[3] LEO Pharma, Madison, NJ USA
[4] Anal Grp Inc, London, England
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2024年 / 190卷
关键词：
atopic dermatitis; work productivity and activity impairment; disease burden; comorbidity;
D O I：
10.1093/bjd/ljad498.047
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
547
引用
收藏
页码：II45 / II46
页数：2
相关论文
共 50 条
  • [1] Symptom burden of patients with moderate-to-severe atopic dermatitis
    Alexander Egeberg
    Peter Anderson
    James Piercy
    Lucy Massey
    Joseph C. Cappelleri
    Gerardo A. Encinas
    Claire Feeney
    Marco Dibonaventura
    European Journal of Dermatology, 2021, 31 : 752 - 758
  • [2] Symptom burden of patients with moderate-to-severe atopic dermatitis
    Egeberg, Alexander
    Anderson, Peter
    Piercy, James
    Massey, Lucy
    Cappelleri, Joseph C.
    Encinas, Gerardo A.
    Feeney, Claire
    Dibonaventura, Marco
    EUROPEAN JOURNAL OF DERMATOLOGY, 2021, 31 (06) : 752 - 758
  • [3] Burden of moderate-to-severe atopic dermatitis on work productivity and the impact of dupilumab on work productivity in Japanese patients: A single-center retrospective study
    Sakurai, Emi
    Kamata, Masahiro
    Uchida, Hideaki
    Tada, Yayoi
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB23 - AB23
  • [4] Conjunctivitis Among Individuals with Moderate-to-Severe Atopic Dermatitis Treated with Dupilumab in the United States
    Franklin, Jessica M.
    Marcus, Andrea F.
    Sultan, Ihtisham
    Howell, Ashley
    Sinnott, Sarah-Jo
    Green, Jeannette
    Ezzy, Stephen M.
    Gately, Robert
    Sobel, Rachel E. E.
    Wang, Florence
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 77 - 78
  • [5] WORK ABILITY AND QUALITY OF WORKING LIFE IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
    Bosma, Angela L.
    Ouwerkerk, Wouter
    Gunal, Merve
    Hyseni, Arienna M.
    Arents, Bernd W. M.
    Gerbens, Louise A. A.
    Middelkamp-Hup, Maritza A.
    de Boer, Angela G. E. M.
    Spuls, Phyllis I.
    ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 32 - 32
  • [6] Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
    Smith, Brandon I.
    Engel, Priya
    Wu, Jashin
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (24): : 2299 - 2300
  • [7] Clinical Approach to Patients with Moderate-to-Severe Atopic Dermatitis: A Spanish Delphi Consensus
    Pereyra-Rodriguez, Jose J.
    Baldrich, Esther S.
    Ruiz-Villaverde, Ricardo
    Torres, Eulalia B.
    Dobao, Pablo De La C.
    Nart, Ignasi F.
    Menendez, Angeles F.
    Martin-santiago, Ana
    Miquel, Javier M.
    Silvestre, Juan F.
    Armario-Hita, Jose C.
    ACTA DERMATO-VENEREOLOGICA, 2023, 103
  • [8] Economic Burden of Itch-Related Sleep Loss in Moderate-to-Severe Atopic Dermatitis in the United Kingdom
    Pierce, Evangeline J.
    Burge, Russel T.
    Hirst, Alex J.
    Fox, Aimee M.
    Suokas, Anu K.
    Yi, Yunni
    DERMATOLOGY AND THERAPY, 2024, 14 (05) : 1103 - 1114
  • [9] Baricitinib for the treatment of pediatric patients with moderate-to-severe atopic dermatitis
    Paller, Amy
    Chu, Chia-Yu
    Yang, Chin-Yi
    Janes, Jonathan
    Prakash, Apurva
    Rueda, Maria Jose
    Stanley, Sarah
    Wu, Wen-Shuo
    Zhang, Xin
    Eichenfield, Lawrence
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB108 - AB108
  • [10] Disease severity and needs of patients with moderate-to-severe Atopic Dermatitis
    Siegels, D.
    Abraham, S.
    Heinrich, L.
    Birkner, T.
    Haufe, E.
    Weidinger, S.
    Werfel, T.
    Schmitt, J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (12) : S197 - S197
12345